Independent Bk Cp (IBCP) 14.60 $IBCP Independent Bank

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Independent Bk Cp (IBCP) 14.60 $IBCP

Independent Bank Corporation Announces Date for Its Second Quarter 2016 Earnings Release
GlobeNewswire - Tue Jun 28, 1:31PM CDT
Independent Bank Corporation (Nasdaq:IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2016 second quarter financial results on Thursday, July 28, 2016, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the "News" section of the "Investor Relations" area of the Company's website.
IBCP: 14.60 (+0.23)

Independent Bank Corporation Announces Cash Dividend on Its Common Stock and Expanded Share Repurchase Plan
GlobeNewswire - Tue Apr 26, 1:28PM CDT
Independent Bank Corporation (NASDAQ:IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that today its Board of Directors declared a quarterly cash dividend on its common stock of eight cents per share. This dividend is payable on May 16, 2016 to shareholders of record on May 6, 2016.
IBCP: 14.60 (+0.23)

Independent Bank posts 1Q profit
Automated Insights - Mon Apr 25, 7:13AM CDT
GRAND RAPIDS, Mich. (AP) _ Independent Bank Corp. (IBCP) on Monday reported first-quarter profit of $4.1 million.
IBCP: 14.60 (+0.23)

Independent Bank Corporation Reports 2016 First Quarter Results
GlobeNewswire - Mon Apr 25, 7:01AM CDT
Independent Bank Corporation (NASDAQ:IBCP) reported first quarter 2016 net income of $4.1 million, or $0.19 per diluted share, versus net income of $3.8 million, or $0.16 per diluted share, in the prior-year period.
IBCP: 14.60 (+0.23)

The Zacks Analyst Blog Highlights: First Interstate Bancsystem, Chemical Financial, Independent Bank, Mercantile Bank and MainSource Financial Group
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 8:30AM CDT
The Zacks Analyst Blog Highlights: First Interstate Bancsystem, Chemical Financial, Independent Bank, Mercantile Bank and MainSource Financial Group
FIBK: 27.77 (+0.35), IBCP: 14.60 (+0.23), MBWM: 24.11 (+0.49), MSFG: 22.01 (+0.45), CHFC: 37.28 (+0.57)

5 Midwest Banks Poised to Outperform
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 1:04PM CDT
Before you decide to totally avoid banking stocks, we would like to inform you that there are many smaller regional Midwest banks that are set to outperform.
FIBK: 27.77 (+0.35), IBCP: 14.60 (+0.23), MBWM: 24.11 (+0.49), MSFG: 22.01 (+0.45), CHFC: 37.28 (+0.57)

Independent Bank Corporation Announces Date for Its First Quarter 2016 Earnings Release
GlobeNewswire - Mon Mar 14, 6:17PM CDT
Independent Bank Corporation (Nasdaq:IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2016 first quarter financial results on Monday, Apr. 25, 2016, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the "News" section of the "Investor Relations" area of the Company's website.
IBCP: 14.60 (+0.23)

Independent Bank Corporation Reports 2015 Fourth Quarter and Full Year Results and 2016 Share Repurchase Authorization
GlobeNewswire - Mon Jan 25, 7:00AM CST
Independent Bank Corporation (Nasdaq:IBCP) reported fourth quarter 2015 net income of $5.6 million, or $0.25 per diluted share, versus net income of $3.9 million, or $0.17 per diluted share, in the prior-year period.
IBCP: 14.60 (+0.23)

Independent Bank Corporation Announces Cash Dividend on Its Common Stock
GlobeNewswire - Fri Jan 22, 8:37AM CST
Independent Bank Corporation (NASDAQ:IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that on Jan. 21, 2016 its Board of Directors declared a quarterly cash dividend on its common stock of eight cents per share. This dividend is payable on Feb. 16, 2016 to shareholders of record on Feb. 5, 2016.
IBCP: 14.60 (+0.23)

Independent Bank Has Returned 13.6% Since SmarTrend Recommendation (IBCP)
Comtex SmarTrend(R) - Wed Jan 06, 9:38AM CST
SmarTrend identified an Uptrend for Independent Bank (NASDAQ:IBCP) on December 23rd, 2014 at $12.85. In approximately 13 months, Independent Bank has returned 13.62% as of today's recent price of $14.60.
IBCP: 14.60 (+0.23)

Shares of IBCP Up 19.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 29, 5:52PM CST
SmarTrend identified an Uptrend for Independent Bank (NASDAQ:IBCP) on December 23rd, 2014 at $12.85. In approximately 12 months, Independent Bank has returned 19.14% as of today's recent price of $15.31.
IBCP: 14.60 (+0.23)

Financial Sector Equities in Motion -- LGI Homes, Forestar Group, Green Brick Partners, and Independent Bank
ACCESSWIRE - Wed Dec 16, 7:02AM CST
NEW YORK, NY / ACCESSWIRE / December 16, 2015 / Park Lane Advisor has initiated coverage on the following equities: LGI Homes Inc. (NASDAQ: LGIH), Forestar Group Inc. (NYSE: FOR), Green Brick Partners Inc. (NASDAQ: GRBK), and Independent Bank Corporation (NASDAQ: IBCP). Free research report on LGI Homes can be accessed at http://www.parklaneadvisor.com/ On Tuesday, December 15, 2015, the NASDAQ Composite ended at 4,995.36, up 0.87%, the Dow Jones Industrial Average advanced 0.90%, to finish the day at 17,524.91, and the S&P 500 closed at 2,043.41, up 1.06%. The gains were broad based as seven out of nine sectors ended the session in positive. Register for your complimentary reports at the links given below.
FOR: 12.05 (+0.24), LGIH: 34.01 (+1.23), GRBK: 7.36 (+0.11), IBCP: 14.60 (+0.23)

Uptrend Call Working As Independent Bank Stock Rises 17.7% (IBCP)
Comtex SmarTrend(R) - Mon Dec 07, 5:03PM CST
SmarTrend identified an Uptrend for Independent Bank (NASDAQ:IBCP) on December 23rd, 2014 at $12.85. In approximately 12 months, Independent Bank has returned 17.74% as of today's recent price of $15.13.
IBCP: 14.60 (+0.23)

Uptrend Call Working As Independent Bank Stock Rises 21.4% (IBCP)
Comtex SmarTrend(R) - Mon Nov 30, 2:56PM CST
SmarTrend identified an Uptrend for Independent Bank (NASDAQ:IBCP) on December 23rd, 2014 at $12.85. In approximately 11 months, Independent Bank has returned 21.40% as of today's recent price of $15.60.
IBCP: 14.60 (+0.23)

20.0% Return Seen to Date on SmarTrend Independent Bank Call (IBCP)
Comtex SmarTrend(R) - Mon Nov 23, 10:02AM CST
SmarTrend identified an Uptrend for Independent Bank (NASDAQ:IBCP) on December 23rd, 2014 at $12.85. In approximately 11 months, Independent Bank has returned 20.00% as of today's recent price of $15.42.
IBCP: 14.60 (+0.23)

Independent Bank Shares Up 17.4% Since SmarTrend's Buy Recommendation (IBCP)
Comtex SmarTrend(R) - Mon Nov 16, 10:03AM CST
SmarTrend identified an Uptrend for Independent Bank (NASDAQ:IBCP) on December 23rd, 2014 at $12.85. In approximately 11 months, Independent Bank has returned 17.35% as of today's recent price of $15.08.
IBCP: 14.60 (+0.23)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading